Inventor

RIVARD MICHAEL

US13 patents

⚠️ This page may combine multiple inventors who share the name “RIVARD MICHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ROUSSY INST GUSTAVE

3 patents

US10125157B2Nov 13, 2018

Derivatives of oxazaphosphorines that are pre-activated, use and method of preparation

ROUSSY INST GUSTAVE0 citations47

US9428530B2Aug 30, 2016

Derivatives of oxazaphosphorines that are pre-activated, use and method of preparation

ROUSSY INST GUSTAVE0 citations47

US10098901B2Oct 16, 2018

Derivatives of oxazaphosphorines and therapeutic uses thereof

ROUSSY INST GUSTAVE0 citations45

RIVARD COMPANIES INC

2 patents

USD898122SOct 6, 2020

Throwing game board

RIVARD COMPANIES INC8 citations79

US12246232B2Mar 11, 2025

Method and apparatus for bag throwing game

RIVARD COMPANIES INC0 citations58

RIVARD LISA

1 patent

USD722527SFeb 17, 2015

Plant and vegetable trough with crossed supports

RIVARD LISA14 citations72

VAXDESIGN CORP

1 patent

US7709256B2May 4, 2010

Disease model incorporation into an artificial immune system (AIS)

VAXDESIGN CORP6 citations72

WARREN WILLIAM L

1 patent

US8119403B2Feb 21, 2012

Disease model incorporation into an artificial immune system (AIS)

WARREN WILLIAM L2 citations61

EATON CORP

1 patent

US5724851AMar 10, 1998

Method and apparatus for forming a leaf spring eye

EATON CORP6 citations61

RIVARD MICHAEL

1 patent

US8096234B2Jan 17, 2012

Apparatus and method for wood mulch bales

RIVARD MICHAEL4 citations55

PACI ANGELO

1 patent

US9073957B2Jul 7, 2015

Derivatives of oxazaphosphorines that are pre-activated, use and method of preparation

PACI ANGELO1 citations49

UNIV PARIS VAL DE MARNE

1 patent

US9944669B2Apr 17, 2018

Fumarate-CO-releasing molecule hybrids, their use in the treatment of inflammatory or cardiovascular diseases and their process of preparation

UNIV PARIS VAL DE MARNE0 citations30

CENTRE NAT RECH SCIENT

1 patent

US10519179B2Dec 31, 2019

Highly efficient NRF2 activators-co-releasing molecule hybrids, their use in the treatment of inflammatory or cardiovascular diseases and their process of preparation

CENTRE NAT RECH SCIENT0 citations29